Optibiotix Health - Microbiome Specialist Entering Commercial Phase

Written by Riccardo Lowi

OptiBiotix Health Plc (LON:OPTI) focuses on managing and treating widespread, chronic medical conditions, such as obesity and high cholesterol, through the modulation of the human microbiome.

Finally, it is worth highlighting the significant operating leverage of the business, as OptiBiotix is run on a very asset-light infrastructure. Products manufacturing is outsourced, and low fixed admin and selling expenses ensure a significant margin expansion, as revenue will keep growing over the next few years.


Latest Research